These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 28192058)

  • 1. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
    Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
    Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues.
    Riesco-Eizaguirre G; Santisteban P; De la Vieja A
    Endocr Relat Cancer; 2021 Sep; 28(10):T141-T165. PubMed ID: 34387194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Na+/I- symporter (NIS): mechanism and medical impact.
    Portulano C; Paroder-Belenitsky M; Carrasco N
    Endocr Rev; 2014 Feb; 35(1):106-49. PubMed ID: 24311738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.
    Dohán O; Carrasco N
    Mol Cell Endocrinol; 2003 Dec; 213(1):59-70. PubMed ID: 15062574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
    Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
    J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The practical relevance of the sodium iodide symporter].
    Spitzweg C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells.
    Dohán O; De la Vieja A; Carrasco N
    Mol Endocrinol; 2006 May; 20(5):1121-37. PubMed ID: 16439463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sodium/iodide symporter: state of the art of its molecular characterization.
    Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary I(-) absorption: expression and regulation of the Na(+)/I(-) symporter in the intestine.
    Nicola JP; Carrasco N; Masini-Repiso AM
    Vitam Horm; 2015; 98():1-31. PubMed ID: 25817864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
    Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
    Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide.
    Josefsson M; Grunditz T; Ohlsson T; Ekblad E
    Acta Physiol Scand; 2002 Jun; 175(2):129-37. PubMed ID: 12028133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
    Schmutzler C; Köhrle J
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
    Carvalho DP; Ferreira AC
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sodium iodide symporter: its pathophysiological and therapeutic implications.
    Spitzweg C; Morris JC
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):559-74. PubMed ID: 12390328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
    De La Vieja A; Dohan O; Levy O; Carrasco N
    Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.
    Dohán O; De la Vieja A; Paroder V; Riedel C; Artani M; Reed M; Ginter CS; Carrasco N
    Endocr Rev; 2003 Feb; 24(1):48-77. PubMed ID: 12588808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].
    Spitzweg C
    Internist (Berl); 2003 Apr; 44(4):396-402, 404-8, 410-1. PubMed ID: 12914397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
    Kogai T; Taki K; Brent GA
    Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium iodide symporter: its role in nuclear medicine.
    Chung JK
    J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.